" class="no-js "lang="en-US"> Companies Archive - Page 72 of 145 - Medtech Alert
Friday, July 03, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Invitae | Pharmtech Focus

Invitae

View Company

 Curve Therapeutics | Pharmtech Focus

Curve Therapeutics

View Company

 OxDX | Pharmtech Focus

OxDX

View Company

 AffaMed Therapeutics | Pharmtech Focus

AffaMed Therapeutics

View Company

 Biohaven | Pharmtech Focus

Biohaven

View Company

 Variantyx | Pharmtech Focus

Variantyx

View Company

 MayaMD | Pharmtech Focus

MayaMD

View Company

 Enterprise Therapeutics | Pharmtech Focus

Enterprise Therapeutics

View Company

 Green Door Clinic | Pharmtech Focus

Green Door Clinic

View Company

 Alex Therapeutics | Pharmtech Focus

Alex Therapeutics

Load More Results